Bristol Myers is the namesake of The Myers Law Firm. He is a native Texan, born in Big Spring and raised in Houston. Bristol graduated from Texas A&M University in 1996. He majored in political science and served as a distinguished member of the Corps of Cadets. He remains active in the Aggie Network through his participation in the Association of Former Students and the Capitol City A&M Club.

In 1999, Bristol graduated with honors from Valparaiso University School of Law, settled in Austin, and went directly into private practice. An ardent defender of those accused of crimes, he is proud to have never worked as a prosecutor.

Eight months after he was licensed to practice law, he earned front page headlines for his defense of a mother facing extradition for parental kidnapping charges. Since that time, his trial experience has covered a vast array of offenses from DWI, assault and drug cases, to capital murder and securities fraud.

"The variety of cases this firm handles is a direct reflection of my desire and ability to help people from all walks of life."

Bristol-Myers Squibb - Corporate Responsibility - Grants
Bristol-Myers Squibb is a global pharmaceutical company whose mission is to extend and enhance human life by developing ... non-profit 501(c)(3) organizations. ...

TX Criminal Defense Lawyer | Texas DWI / DUI Attorney Austin
Bristol Myers & Associates, P.C. provides effective criminal defense ... At Bristol Myers & Associates, P.C., we represent individuals facing criminal ...

Bristol-Myers Squibb Newsroom: Home
Bristol-Myers Squibb is a global pharmaceutical company whose mission is to extend and enhance human life by developing ... Hepatitis C Awareness, Prevention ...

Bristol-Myers Squibb Newsroom: News Releases
Bristol-Myers Squibb is a global pharmaceutical company whose mission is to extend and enhance human life by developing ... Hepatitis C is a virus that ...

ImClone/Lilly boards OK $6.5B merger - Indianapolis Star
stv.tvImClone/Lilly boards OK $6.5B mergerIndianapolis Star, United States - Oct 6, 2008In accepting Lilly's offer, ImClone turned its back on its longtime partner, Bristol-Myers Squibb, which had offered $60 a share for the company last month, ...Eli Lilly to Buy ImClone for $6.5 Billion New York TimesLilly to Acquire ImClone Systems in $6.5 Billion Transaction MarketWatchImClone deal is latest bold move by new Lilly CEO ReutersRedOrbit - Minyanville.comall 839 news articles

Lilly Holds Talks With ImClone for Potential Bid - New York Times
Dividend.comLilly Holds Talks With ImClone for Potential BidNew York Times, United States - Oct 1, 2008ImClone has said that the Bristol-Myers bid undervalues the company. But it is possible that Mr. Icahn is seeking to force a higher bid from Bristol-Myers, ...The real ImClone mystery? The price. Reuters UKImClone in Negotiations with Mystery Bidder Pharmaceutical Technology MagazineLilly Is Potential ImClone Suitor With $6.1 Billion Offer New York Timesall 243 news articles

Bidder for ImClone Nearing a Decision, Icahn Says - New York Times
Wall Street JournalBidder for ImClone Nearing a Decision, Icahn SaysNew York Times, United States - Sep 29, 2008The potential offer would top a $62-a-share hostile bid from the Bristol-Myers Squibb Company, ImClone??™s marketing partner for the cancer drug Erbitux and ...Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone ... WELT ONLINEDrug stocks climb; Sequenom, Vertex soar MarketWatchTempers Flare In Bristol Bid for ImClone NJBIZPharmalot - Business Wire (press release)all 481 news articles

Doubts Grow Over Lilly??™s ImClone Deal - New York Times Blogs
BusinessWeekDoubts Grow Over Lilly??™s ImClone DealNew York Times Blogs, NY - Oct 10, 2008... some analysts questioned the price tag, wondering if the pharmaceutical giant hadn??™t overpaid to beat out an offer of $62 a share from Bristol-Myers ...Lilly to Acquire ImClone for $6.5 billion Pharmaceutical Technology MagazineLilly Offers $6.5 Billion for ImClone Pharmaceutical Technology Magazineall 31 news articles